Lundbeck (United States)

Lundbeck is a Danish pharmaceutical company specializing in brain diseases including depression, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and migraine. Key products include Trintellix (vortioxetine) and Rexulti (brexpiprazole) for depression, Abilify Maintena for schizophrenia, and Vyepti (eptinezumab) for migraine prevention. Lundbeck’s neuroscience focus advances understanding and treatment of psychiatric and neurological disorders.